Publications by authors named "Issa Khouri"

Claim this Profile
C
Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia.
Hannah Goulart, Farhad Ravandi, Nicholas J Short, Nitin Jain, Naval Daver, Issa Khouri

JCO Precis Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex vivo mesenchymal progenitor cell-based cord blood cell expansion and exofucosylation to enhance transplant engraftment.
Portia Smallbone, Mayela Mendt, Robert Sackstein, Mark R Tanner, Indresh Kaur, Issa Khouri

Cytotherapy· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Hematopoietic Stem Cell Transplantation Following CAR T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia.
Natalie Rafaeli, David Marin Costa, Celina Ledesma, Nitin Jain, Priti Tewari, Issa Khouri

Clin Lymphoma Myeloma Leuk· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin.
Jayastu Senapati, Elias Jabbour, Nicholas J Short, Nitin Jain, Fadi Haddad, Issa Khouri

Blood Cancer J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis.
Alexandre E Malek, Taha Al-Juhaishi, Denái R Milton, Jeremy L Ramdial, May Daher, Issa F Khouri

Bone Marrow Transplant· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial.
Issa F Khouri, Kamal Alzahrani, Hagop Kantarjian, Denái R Milton, Alison M Gulbis

Am J Hematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
Sairah Ahmed, Qaiser Bashir, Roland L Bassett, Fauzia Ullah, Fleur Aung, Issa Khouri

Am J Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation.
Curtis Marcoux, Rima M Saliba, Whitney Wallis, Sajad Khazal, Dristhi Ragoonanan, Issa Khouri

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities.
Uday R Popat, Oren Pasvolsky, Roland Bassett, Rohtesh S Mehta, Amanda Olson, Issa Khouri

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant.
Taha Al-Juhaishi, Yingjun Wang, Denái R Milton, Zijun Y Xu-Monette, Elias Jabbour, Issa F Khouri

Bone Marrow Transplant· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia.
Hagop Kantarjian, Fadi G Haddad, Nitin Jain, Koji Sasaki, Nicholas J Short, Issa Khouri

J Hematol Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors.
Elias J Jabbour, Koji Sasaki, Fadi G Haddad, Ghayas C Issa, Guillermo Garcia-Manero, Issa F Khouri

Am J Hematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA Factors versus Non-HLA Factors for Haploidentical Donor Selection.
Rohtesh S Mehta, Kai Cao, Rima M Saliba, Gheath Al-Atrash, Amin M Alousi, Issa Khouri

Transplant Cell Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results.
Hagop Kantarjian, Nicholas J Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Issa Khouri

Am J Hematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies.
Harjeet Singh, Samer A Srour, Denái R Milton, Jessica McCarty, Cuiping Dai, Issa Khouri

Front Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Transplantation Cyclophosphamide Versus Tacrolimus and Methotrexate Graft-Versus-Host Disease Prophylaxis for HLA-Matched Donor Transplantation.
Rohtesh S Mehta, Rima M Saliba, Gabriela Rondon, Gheath Al-Atrash, Qaiser Bashir, Issa Khouri

Transplant Cell Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycophenolate Mofetil: A Friend or a Foe with Post-Transplantation Cyclophosphamide and Tacrolimus Prophylaxis in HLA-Matched Donors?
Rohtesh S Mehta, Rima M Saliba, Eiko Hayase, Robert R Jenq, Susan Abraham, Issa Khouri

Transplant Cell Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide.
Rohtesh S Mehta, Rima M Saliba, Sassine Ghanem, Amin M Alousi, Gabriela Rondon, Issa Khouri

Transplant Cell Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement.
Serkan Akin, Chitra Hosing, Issa Khouri, Sairah Ahmed, Amin Alousi

Blood Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome of allogeneic stem cell transplantation in patients with B-cell lymphoid malignancies following treatment with targeted small molecule inhibitors.
Akash Mukherjee, Denái R Milton, Elias J Jabbour, Alison M Gulbis, Tapan Kadia, Issa F Khouri

Leuk Lymphoma· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia.
Mahmoud R Gaballa, Pinaki Banerjee, Denái R Milton, Xianli Jiang, Christina Ganesh, Issa Khouri

Blood· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Qaiser Bashir, Denái R Milton, Uday R Popat, Partow Kebriaei, Chitra Hosing, Issa F Khouri

Bone Marrow Transplant· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide.
Rohtesh S Mehta, Rima M Saliba, Leonard C Alsfeld, Jeffrey L Jorgensen, Sa A Wang, Issa Khouri

Transplant Cell Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative Fractionated Busulfan With Fludarabine in Older Patients: Long Term Disease-Specific Outcomes of a Prospective Phase II Clinical Trial.
Rohtesh S Mehta, Roland Bassett, Julianne Chen, Benigno C Valdez, Jitesh Kawedia, Issa Khouri

Transplant Cell Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous Transplant.
Issa F Khouri, Denái R Milton, Alison M Gulbis, Elias J Jabbour, Loretta Nastoupil

Clin Cancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis